CNS Pharmaceuticals Inc.

Jan 14, 2020

CNS Pharmaceuticals Announces Contract with International GMP Manufacturer for Production of Berubicin

Dec 10, 2019

CNS Pharmaceuticals Received Positive FDA Pre-IND Guidance for Berubicin

Dec 09, 2019

CNS Pharmaceuticals to Participate in the 8th Annual ROTH Deer Valley Corporate Access Event

Dec 03, 2019

CNS Pharmaceuticals to Participate in 12th Annual LD Micro Main Event Conference

Nov 26, 2019

CNS Pharmaceuticals Entered $2.0 Million Sublicense Agreement with WPD Pharmaceuticals

Nov 21, 2019

CNS Pharmaceuticals Announces Full Exercise of Over-Allotment Option

Nov 21, 2019

CNS Pharmaceuticals Filed Request with FDA for Pre-IND Meeting for Berubicin

Nov 20, 2019

CNS Pharmaceuticals Announces Attendance at the 24th Annual Meeting of the Society of Neuro-Oncology